GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 16 filers reported holding GENETIC TECHNOLOGIES LTD in Q2 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $21,000 | -89.1% | 11,208 | -82.0% | 0.00% | – |
| Q3 2021 | $193,000 | -42.9% | 62,408 | -21.5% | 0.00% | – |
| Q2 2021 | $338,000 | +65.7% | 79,510 | +62.8% | 0.00% | – |
| Q1 2021 | $204,000 | +191.4% | 48,835 | +149.5% | 0.00% | – |
| Q4 2020 | $70,000 | +42.9% | 19,570 | +37.8% | 0.00% | – |
| Q3 2020 | $49,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |